KDR and neoplasm: Among the bioactive compounds identified, specific peptides from the cyanobacterium Lyngbya majuscula, such as Isomalyngamide A and A-1, have demonstrated particularly potent anticancer properties by inhibiting VEGFR2 and MMP-9, which are critical factors in tumor growth and metastasis.